nialamide has been researched along with Cataract in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| YAMAMOTO, Y | 1 |
| HIKAWA, T | 1 |
| KATO, M | 1 |
| KITSUKAWA, H | 1 |
1 other study available for nialamide and Cataract
| Article | Year |
|---|---|
[EFFECT OF NIAMID IN OPHTHALMOLOGY].
Topics: Adolescent; Asthenopia; Cataract; Geriatrics; Glaucoma; Neurotic Disorders; Nialamide; Ophthalmology | 1963 |